SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy set for Rs 1000 crore boost from Valtrex clone

27 Nov 2009 Evaluate

Gurgaon-based Ranbaxy Laboratories has launched generic Valtrex (valacyclovir hydrochloride) tablets in the US, over two years after it settled a patent dispute with GlaxoSmithKline (GSK) and secured a 180-day sales exclusivity for it.

 

It has launched 500 mg and 1 gm tablets of valacyclovir hydrochloride in the US market. The opportunity is worth about $200 million, or Rs 1,000 crore, for Ranbaxy. Valacyclovir is an antiviral drug used to treat genital herpes, cold sores and shingles. It is also categorised as a prodrug, which means a pharmacological substance that is administered in an inactive form but metabolises into an active form within the body.

 

The US Patent and Trademark Office first issued a patent on valacyclovir to Burroughs Wellcome Co in 1990. In 1995, Glaxo Inc merged with Burroughs Wellcome to become Smithkline Beecham Corp and started doing business as GSK. In 2003, GSK filed a law suit against Ranbaxy, charging it with infringement of its patent on the drug. Ranbaxy, too, filed a suit challenging the validity of GSK's patent. In July 2007, the two companies reached an agreement and settled the dispute.

crackcrack
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×